Downstream Effects of Airway Mucus Plugs on 129Xenon MRI Following Biologic Therapy

Status: Recruiting
Location: See location...
Intervention Type: Combination product
Study Type: Observational
SUMMARY

In this study, xenon MRI will be used to evaluate regional functional consequences of mucus plugs in the lungs of patients with severe asthma. Mucus plugs will be identified using CT imaging, and xenon MRI will be used to evaluate ventilation and gas exchange impairments in regions of the lungs corresponding to the airways downstream of mucus plugs.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:

• Adequate completion of informed consent process with written documentation

• Patients 18 - 65 years old

• Physician diagnosis of asthma for \> 1 year

• Able to perform reproducible spirometry according to ATS criteria based on clinical PFTs within previous 30 days of enrollment

• All racial/ethnic backgrounds may participate

• Blood eosinophil count \> 300 cells/μL

• Smoking history \<10 pack years

• No smoking history (including vapes, cigar, or marijuana use) in the last 3 months

• About to initiate asthma therapy with either dupilumab, tezepelumab, or benralizumab as part of their standard of care

Locations
United States
North Carolina
Duke University Medical Center
RECRUITING
Durham
Contact Information
Primary
David Mummy, PhD
david.mummy@duke.edu
9846847783
Backup
Bastiaan Driehuys, PhD
bastiaan.driehuys@duke.edu
919-684-7786
Time Frame
Start Date: 2025-11-17
Estimated Completion Date: 2027-09
Participants
Target number of participants: 5
Related Therapeutic Areas
Sponsors
Leads: Bastiaan Driehuys
Collaborators: University of Kansas Medical Center, Polarean, Inc.

This content was sourced from clinicaltrials.gov